FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to chemical-pharmaceutical industry and presents using (-)-(3aR,4S,7aR)-4-hydroxy-4-m-tolylethinyloctahydroindole-1-carboxylic acid methyl ester for treating, preventing or arresting the development of dyskinesia caused by levodopa (L-dopa) in treating Parkinson's disease.
EFFECT: invention refers to a pharmaceutical composition, a kit and a foodstuff containing (-)-(3aR,4S,7aR)-4-hydroxy-4-m-tolylethinyloctahydroindole-1-carboxylic acid methyl ester.
5 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATIONS CONTAINING mGluR MODULATORS FOR TREATING PARKINSON'S DISEASE | 2009 |
|
RU2496494C2 |
| ACETYLENE DERIVATIVES, METHOD OF THEIR OBTANING, PHARMACEUTICAL COMPOSITION BASED ON THEM AND THEIR USE AS ANTAGONISTS OF METABOTHROPIC GLUTAMATE RECEPTORS (MGLUR5) | 2002 |
|
RU2341515C2 |
| ETHYNYL DERIVATIVES | 2016 |
|
RU2712633C1 |
| APPLICATION OF ANTAGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS (mGLuR5), ESPECIALLY AFQ056, FOR TREATMENT OF GASTROINTESTINAL TRACT (GIT), ESPECIALLY GASTROESOPHAGEAL REFLUX (GER) | 2006 |
|
RU2422138C2 |
| PHENYLETHENYL- OR PHENYLETHYNYL-DERIVATIVES AS ANTAGONISTS OF GLUTAMATE RECEPTORS | 2001 |
|
RU2284323C9 |
| NEW DERIVATIVES OF AMINOPYRIDINE AS ANTAGONISTS mGIuR5 | 2004 |
|
RU2330020C2 |
| 2-OXA-5-AZABICYCLO[2.2.1]HEPTANE-3-YL DERIVATIVES | 2015 |
|
RU2697651C2 |
| SUBSTITUTED DIAMINOCARBOXAMIDE AND DIAMINOCARBONITRILE DERIVATIVES OF PYRIMIDINES, COMPOSITIONS THEREOF AND METHODS OF TREATING USE THEREOF | 2012 |
|
RU2697712C2 |
| CHEMOKINE RECEPTOR ANTAGONISTS | 2005 |
|
RU2395506C2 |
| METHOD OF PRODUCING SUBSTITUTED 3-ARYLBUTYLAMINE COMPOUNDS | 2004 |
|
RU2380355C2 |
